| Catalyst Medical Group, Pllc | |
| 320 Warner Dr, Lewiston, Idaho 83501 | |
| (208) 743-3523 |
| Name | Catalyst Medical Group, Pllc |
|---|---|
| Organization Name | Catalyst Medical Group, Pllc |
| Location | 320 Warner Dr, Lewiston, Idaho 83501 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 743-3523 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Farmers Insurance Exchange, 21st Century Insurance Company, Coast National Insurance Company, Mid-Century Insurance Company, and Truck Insurance Exchange (collectively, "Farmers") have reached a settlement in a lawsuit involving alleged billing fraud by two radiological companies and their owners.
Adventist Medical Center is now home to the newest model of the da Vinci surgical robot. The da Vinci robot enables complex surgeries to be completed using a minimally invasive approach. The approach minimizes the physical and emotional impact of surgery on patients resulting in increased quality outcomes. The Portland, Ore., based hospital is one of few hospitals in the Northwest to use the latest model of the da Vinci Robotic Surgical System.
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide's JBI, an international research organisation in the Faculty of Health and Medical Sciences.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
› Verified 9 days ago
| NPI Number | 1023545373 |
| Organization Name | CATALYST MEDICAL GROUP, PLLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 320 Warner Dr, Lewiston, ID 83501 |
| Phone Number | 208-743-3523 |
News Archive
Farmers Insurance Exchange, 21st Century Insurance Company, Coast National Insurance Company, Mid-Century Insurance Company, and Truck Insurance Exchange (collectively, "Farmers") have reached a settlement in a lawsuit involving alleged billing fraud by two radiological companies and their owners.
Adventist Medical Center is now home to the newest model of the da Vinci surgical robot. The da Vinci robot enables complex surgeries to be completed using a minimally invasive approach. The approach minimizes the physical and emotional impact of surgery on patients resulting in increased quality outcomes. The Portland, Ore., based hospital is one of few hospitals in the Northwest to use the latest model of the da Vinci Robotic Surgical System.
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide's JBI, an international research organisation in the Faculty of Health and Medical Sciences.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
› Verified 9 days ago
News Archive
Farmers Insurance Exchange, 21st Century Insurance Company, Coast National Insurance Company, Mid-Century Insurance Company, and Truck Insurance Exchange (collectively, "Farmers") have reached a settlement in a lawsuit involving alleged billing fraud by two radiological companies and their owners.
Adventist Medical Center is now home to the newest model of the da Vinci surgical robot. The da Vinci robot enables complex surgeries to be completed using a minimally invasive approach. The approach minimizes the physical and emotional impact of surgery on patients resulting in increased quality outcomes. The Portland, Ore., based hospital is one of few hospitals in the Northwest to use the latest model of the da Vinci Robotic Surgical System.
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry's (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing. GNA Biosolutions also won the audience choice award.
New recommendations for best practice for infection prevention and control in healthcare settings, to help stop the spread of COVID-19, have been developed by the University of Adelaide's JBI, an international research organisation in the Faculty of Health and Medical Sciences.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
› Verified 9 days ago
Owl Home Medical Type: Long Term Care Pharmacy Location: 720 16th Ave, Lewiston, Idaho 83501 Phone: (208) 743-7766 | |
Rite Aid Pharmacy 05408 Type: Medicare Supplier Location: 1904 19th Ave, Lewiston, Idaho 83501 Phone: (208) 743-9127 | |
Walgreens #2679 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2102 Nez Perce Dr, Lewiston, Idaho 83501 Phone: (208) 743-4434 | |
Sav-on Pharmacy #238 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1024 21st St, Lewiston, Idaho 83501 Phone: (208) 743-1529 | |
Rosauers Pharmacy #33 Type: Pharmacy Location: 332 Thain Rd, Lewiston, Idaho 83501 Phone: (208) 743-6511 |